The connected medical devices internet of medical things (IoMT) market size is expected to see rapid growth in the next few years. It will grow to $124.46 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth during the forecast period is driven by growing adoption of connected wearable medical devices, rising demand for personalized healthcare solutions, increasing expansion of home healthcare services, growing need for real-time clinical decision support, and expanding deployment of smart hospital infrastructure. Key trends during the forecast period include increasing adoption of connected medical devices for real-time patient monitoring, growing integration of wearable healthcare devices for continuous health tracking, rising demand for interoperable medical device connectivity solutions, expanding use of remote healthcare monitoring systems for improved patient management, and increasing focus on secure data exchange between medical devices and healthcare systems.
The growing adoption of telehealth and remote patient monitoring is expected to drive the growth of the connected medical devices (IoMT) market in the coming years. Telehealth and remote patient monitoring (RPM) involve the use of digital communication technologies and connected medical devices to deliver healthcare services and continuously monitor patients' health data remotely outside conventional clinical settings. The adoption of telehealth and remote patient monitoring is increasing due to the rising prevalence of chronic diseases, as these solutions enable continuous health monitoring and timely medical care for patients requiring long-term disease management. Connected medical devices (IoMT) facilitate telehealth and remote patient monitoring by continuously collecting and transmitting real-time patient health data to healthcare providers, enabling remote assessment, prompt intervention, and more effective disease management. For example, in August 2025, according to the US Department of Health and Human Services, a US-based government administration, nearly 1 million enrollees received remote patient monitoring services in 2024, representing a 27% increase compared to 2023. Therefore, the growing adoption of telehealth and remote patient monitoring is driving the growth of the connected medical devices (IoMT) market.
Major companies operating in the connected medical devices Internet of Medical Things (IoMT) market are focusing on introducing innovative solutions, such as remote patient management, to support continuous health monitoring, improve patient outcomes, and enhance healthcare delivery efficiency. Remote patient management is a digital healthcare system that utilizes connected medical devices, software, and communication technologies to remotely collect, monitor, and manage patients' health data outside traditional healthcare environments. For example, in March 2023, Royal Philips, a Netherlands-based health technology company, launched Philips Virtual Care Management, a comprehensive telehealth solution designed to help healthcare providers remotely monitor and manage patients across multiple care settings. The platform integrates remote patient monitoring, patient engagement tools, and care coordination capabilities into a unified solution, enabling clinicians to monitor patient health data and intervene proactively when necessary. It utilizes connected medical devices and digital communication technologies to improve patient outcomes, reduce hospital readmissions, and enhance the overall efficiency of healthcare delivery.
In November 2024, Amazon Web Services Inc., a US-based cloud computing company, partnered with Royal Philips to accelerate the migration of healthcare systems to the cloud and support scalable, AI-driven digital health and diagnostic solutions. Through this partnership, the companies aim to modernize healthcare IT infrastructure by migrating clinical and diagnostic systems to the cloud, enabling enhanced data accessibility, greater operational efficiency, and AI-powered clinical decision support. Royal Philips is a Netherlands-based health technology company that provides connected medical devices (IoMT).
Major companies operating in the connected medical devices internet of medical things (iomt) market are Abbott Laboratories, AliveCor Inc., Apple Inc., Becton Dickinson and Company, BioIntelliSense, Boston Scientific Corporation, Cisco Systems, Dexcom Inc., Edwards Lifesciences Corporation, Epitel Inc., F. Hoffmann-La Roche AG, Garmin Ltd., GE HealthCare Technologies Inc., IBM, Intuitive Surgical Inc., Johnson & Johnson, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Microsoft, Olympus Corporation, Omron Corporation, ResMed Inc., Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, Zimmer Biomet Holdings Inc.
North America was the dominating region in the connected medical devices internet of medical things (IoMT) market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the connected medical devices internet of medical things (IoMT) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the connected medical devices internet of medical things (IoMT) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Connected Medical Devices Internet Of Medical Things (IoMT) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses connected medical devices internet of medical things (iomt) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for connected medical devices internet of medical things (iomt)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The connected medical devices internet of medical things (iomt) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:
1) By Component: Devices; Software; Services2) By Connectivity Technology: Wireless Fidelity; Bluetooth; Cellular Networks; Radio Frequency Identification; Near Field Communication; Zigbee
3) By Deployment Mode: Cloud Based; On Premises; Hybrid
4) By Application: Remote Patient Monitoring; Chronic Disease Management; Telemedicine; Clinical Workflow Management; Medication Management; Diagnostic Monitoring; Asset Management
5) By End Use: Hospitals; Clinics; Home Healthcare Settings; Ambulatory Surgical Centers; Diagnostic Centers; Long Term Care Facilities
Subsegments:
1) By Devices: Patient Monitoring Devices; Diagnostic Imaging Devices; Therapeutic Devices; Wearable Medical Devices; Implantable Medical Devices2) By Software: Device Management Software; Remote Monitoring Software; Electronic Health Record Integration Software; Clinical Workflow Management Software; Healthcare Data Analytics Software
3) By Services: Installation And Integration Services; Maintenance And Support Services; Consulting Services; Managed Services; Training And Education Services
Companies Mentioned: Abbott Laboratories; AliveCor Inc.; Apple Inc.; Becton Dickinson and Company; BioIntelliSense; Boston Scientific Corporation; Cisco Systems; Dexcom Inc.; Edwards Lifesciences Corporation; Epitel Inc.; F. Hoffmann-La Roche AG; Garmin Ltd.; GE HealthCare Technologies Inc.; IBM; Intuitive Surgical Inc.; Johnson & Johnson; Koninklijke Philips N.V.; Masimo Corporation; Medtronic plc; Microsoft; Olympus Corporation; Omron Corporation; ResMed Inc.; Siemens Healthineers AG; Stryker Corporation; Terumo Corporation; Zimmer Biomet Holdings Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Abbott Laboratories
- AliveCor Inc.
- Apple Inc.
- Becton Dickinson and Company
- BioIntelliSense
- Boston Scientific Corporation
- Cisco Systems
- Dexcom Inc.
- Edwards Lifesciences Corporation
- Epitel Inc.
- F. Hoffmann-La Roche AG
- Garmin Ltd.
- GE HealthCare Technologies Inc.
- IBM
- Intuitive Surgical Inc.
- Johnson & Johnson
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
- Microsoft
- Olympus Corporation
- Omron Corporation
- ResMed Inc.
- Siemens Healthineers AG
- Stryker Corporation
- Terumo Corporation
- Zimmer Biomet Holdings Inc.

